These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 36217131)

  • 1. Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma.
    Yi F; Zhan C; Liu B; Li H; Zhou J; Tang J; Peng W; Luo W; Chen Q; Lai K
    Respir Res; 2022 Oct; 23(1):279. PubMed ID: 36217131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between montelukast and tiotropium as add-on therapy to inhaled corticosteroids plus a long-acting β
    Hoshino M; Akitsu K; Ohtawa J
    J Asthma; 2019 Sep; 56(9):995-1003. PubMed ID: 30212239
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical, physiological and anti-inflammatory effect of montelukast in patients with cough variant asthma.
    Takemura M; Niimi A; Matsumoto H; Ueda T; Matsuoka H; Yamaguchi M; Jinnai M; Chin K; Mishima M
    Respiration; 2012; 83(4):308-15. PubMed ID: 22094623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of early effects of budesonide/formoterol maintenance and reliever therapy with fluticasone furoate/vilanterol for asthma patients requiring step-up from inhaled corticosteroid monotherapy.
    Hozawa S; Terada M; Haruta Y; Hozawa M
    Pulm Pharmacol Ther; 2016 Apr; 37():15-23. PubMed ID: 26850307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cough, asthma, and cysteinyl-leukotrienes.
    Niimi A
    Pulm Pharmacol Ther; 2013 Oct; 26(5):514-9. PubMed ID: 23774534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Step-down treatment from medium-dosage of budesonide/formoterol in controlled asthma.
    Mori K; Fujisawa T; Inui N; Hashimoto D; Enomoto N; Nakamura Y; Kuroishi S; Yokomura K; Toyoshima M; Imokawa S; Yamada T; Shirai T; Masuda M; Hayakawa H; Chida K; Suda T
    Respir Med; 2016 Oct; 119():1-6. PubMed ID: 27692128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of budesonide/formoterol maintenance and reliever therapy with fluticasone/salmeterol fixed-dose treatment on airway inflammation and small airway impairment in patients who need to step-up from inhaled corticosteroid monotherapy.
    Hozawa S; Terada M; Hozawa M
    Pulm Pharmacol Ther; 2014 Apr; 27(2):190-6. PubMed ID: 24388868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective, observational study of different medication regimens and outcome in children with cough variant asthma.
    Lou N; Ma X; Luo Q; Wei X; Zhang Y; Guo J; Wang J; Gai Z
    Immun Inflamm Dis; 2024 Aug; 12(8):e1357. PubMed ID: 39110093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Add-on montelukast vs double-dose budesonide in nonasthmatic eosinophilic bronchitis: a pilot study.
    Cai C; He MZ; Zhong SQ; Tang Y; Sun BQ; Chen QL; Zhong NS
    Respir Med; 2012 Oct; 106(10):1369-75. PubMed ID: 22819521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.
    Akamatsu T; Shirai T; Kato M; Yasui H; Hashimoto D; Fujisawa T; Tsuchiya T; Inui N; Suda T; Chida K
    Pulm Pharmacol Ther; 2014 Feb; 27(1):52-6. PubMed ID: 23583566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of efficiency and safety of combined montelukast sodium and budesonide in children with cough variant asthma: A protocol for systematic review and meta-analysis.
    Tang Q; Lei H; You J; Wang J; Cao J
    Medicine (Baltimore); 2021 Jun; 100(25):e26416. PubMed ID: 34160429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of beclomethason/formoterol and budesonide/formoterol fixed combinations on lung function and airway inflammation in patients with mild to moderate asthma--an exploratory study.
    Kirsten AM; Watz H; Brindicci C; Piccinno A; Magnussen H
    Pulm Pharmacol Ther; 2015 Apr; 31():79-84. PubMed ID: 25194884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of formoterol or montelukast to low-dose budesonide: an efficacy comparison in short- and long-term asthma control.
    Ceylan E; Gencer M; Aksoy S
    Respiration; 2004; 71(6):594-601. PubMed ID: 15627870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and exhaled nitric oxide.
    Miraglia del Giudice M; Piacentini GL; Capasso M; Capristo C; Maiello N; Boner AL; Capristo AF
    Respir Med; 2007 Aug; 101(8):1809-13. PubMed ID: 17418554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of fluticasone/formoterol with budesonide/formoterol pMDI in adults with moderate to severe persistent asthma: Results from a 12-week randomized controlled trial.
    Balki A; Balamurugan S; Bardapurkar S; Dalal S; Singh A; Singh BP; Vaidya A; Gogtay JA
    Pulm Pharmacol Ther; 2018 Feb; 48():28-36. PubMed ID: 28890299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention.
    Aalbers R; Vogelmeier C; Kuna P
    Respir Med; 2016 Feb; 111():1-7. PubMed ID: 26614594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management.
    Singh D; Garcia G; Maneechotesuwan K; Daley-Yates P; Irusen E; Aggarwal B; Boucot I; Berend N
    Adv Ther; 2022 May; 39(5):1895-1914. PubMed ID: 35284999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ram FS; Cates CJ; Ducharme FM
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitussive effects of the leukotriene receptor antagonist montelukast in patients with cough variant asthma and atopic cough.
    Kita T; Fujimura M; Ogawa H; Nakatsumi Y; Nomura S; Ishiura Y; Myou S; Nakao S
    Allergol Int; 2010 Jun; 59(2):185-92. PubMed ID: 20299826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.